Other News

U.S. FDA Clears Abbott’s High Sensitivity Troponin-I Blood Test That Aids Doctors in Diagnosing Heart Attacks Faster and More Accurately

Newly cleared diagnostic test could help identify heart attacks several hours sooner than standard troponin tests and help improve diagnosis in women ABBOTT PARK, Ill., Sept. 25, 2019 /PRNewswire/ — Abbott (NYSE: ABT) today announced that its ARCHITECT STAT High Sensitivity Troponin-I blood test has received clearance from the U.S. Food and Drug Administration […]

AI-Powered Digital Health Company Eko Closes $20 Million Series B to Continue the Fight Against Heart Disease

Led by ARTIS Ventures, Funding will Drive Further Research and Commercialization of Eko’s Machine Learning Platform San Francisco, CA, Sept. 25, 2019 (GLOBE NEWSWIRE) — Eko, a Silicon Valley-based digital health company building machine learning tools to fight heart disease, today announced it has secured $20 million in Series B funding. […]

Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member

BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) — Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was issued on August 27, 2019 by the United States Patent & Trademark Office with a priority date extending back to July […]

Shockwave Study Demonstrates Strong Safety and Procedural Success of Coronary IVL in Europe

TCT Presentation of DISRUPT CAD II EU Post-Market Study Confirms Promissory DISRUPT CAD I Results Data Published Simultaneously in Circulation: Cardiovascular Interventions SANTA CLARA, Calif., Sept. 25, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, unveiled […]

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion The board of directors of Acarix AB (“Acarix” or the “Company”) has today, pursuant to the authorization granted by the extra general meeting on 16 August 2019, resolved to […]

Teleflex Announces Tenth Anniversary of GuideLiner® Catheter Product Line

Company Celebrates 10 Years of the Industry’s Leading Guide Extension Catheter with More Than 1 Million Units Sold Worldwide WAYNE, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the tenth anniversary of its industry-leading GuideLiner® Catheter. Released in November […]

THE SAGE GROUP LLC Comments on National Peripheral Artery Disease (PAD) Awareness Month

BEAUFORT, S.C.–(BUSINESS WIRE)–According to THE SAGE GROUP, in 2015 almost 20 million Americans suffered from PAD representing an economic burden of $224-$414 billion. “Almost 20 years ago, we wrote that PAD was underestimated, underdiagnosed and undertreated,” stated Mary L. Yost, President. “Unfortunately, this is still true.” Reflecting on the current […]

Vital Metrix Wins 2019 MedTech Breakthrough Awards Program

RESTON, Va.–(BUSINESS WIRE)–Vital Metrix, Inc. today announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has selected the company as the winner of its “Best Biometric Sensor Solution” award in the 2019 MedTech Breakthrough Awards program. Vital Metrix, Inc. […]

Cardiovascular Systems, Inc. Announces FDA Approval of the Coronary ViperWire Advance® With Flex Tip

U.S. Approval of the First and Only Nitinol Atherectomy Guide Wire Expands Company’s Portfolio of Products Targeting Complex Coronary Disease ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced […]

Journal Of Vascular Access Publishes Positive Clinical Results For Bluegrass Vascular’s Surfacer® System

Additional clinical evidence to be highlighted at upcoming Controversies in Dialysis Access (CiDA) and American Society of Nephrology (ASN) meetings SAN ANTONIO, Sept. 24, 2019 /PRNewswire/ — Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of positive results associated […]